$APH

Amphenol (APH) Q2 2026 Earnings Call Transcript

Amphenol (APH) reported Q2 2026 net sales of $8.8 billion, up 55% in U.S. dollars and 30% organically year over year. Adjusted diluted EPS was $1.35. Record orders were $10.7 billion (book-to-bill 1.23). The company raised 2026 CommScope sales guidance to $4.6 billion and accretion to $0.30, and guided Q3 sales to $9.3-$9.4 billion.

Original reporting
Published Aug 7, 2026, 11:58 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 1:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Amphenol (APH) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$APHBullishHigh
01

Why it matters

The most tradable elements are the raised full-year 2026 CommScope sales and accretion guidance, plus Q3 sales and adjusted EPS guidance. Management also highlights AI-driven IT datacom acceleration and a specific risk of demand moderation in communications networks.

02

Market read

Traders can update earnings models immediately using the raised 2026 CommScope guidance and the provided Q3 sales and adjusted EPS ranges, while monitoring the communications networks organic moderation risk.

03

What to watch

Capex may be modestly higher in 2H 2026, and the tariff recovery benefit is a discrete $80M net benefit that may not recur at the same magnitude.

Relevance 9/10Novelty 9/10Timing: post-earnings, after-hours transcript dated Aug 7, 2026

Background

This is the Q2 2026 earnings call transcript for Amphenol, including segment performance, guidance updates, capital return, and management commentary on end-market demand.

Company-level read

Ticker impact

$APHBullishHigh confidence
Context

Amphenol reported Q2 2026 sales of $8.8B (+55% in USD, +30% organic) and raised 2026 CommScope guidance to $4.6B.

Expected impact

Likely positive bias for APH as traders price higher 2026 CommScope revenue and EPS accretion, tempered by the noted communications networks moderation.

Evidence & confidence

The article contains multiple fresh, decision-relevant datapoints: Q2 results, raised full-year 2026 CommScope sales and accretion guidance, and Q3 sales and adjusted EPS guidance, plus a specific risk callout about communications networks demand moderating.

Market effects

Signals continued strength in high-speed, fiber optic, and power interconnect demand tied to AI datacom, while communications networks remains a weaker pocket.

No explicit regional breakdown beyond U.S. dollar vs local currency growth; limited incremental regional trading signal.

AI datacom and defense/industrial end-market strength can influence sentiment across industrial electronics and interconnect peers globally.

Counterpoint

The headline growth is partly acquisition and mix-driven, and management explicitly flags organic moderation in communications networks, which could cap multiple expansion.

Key entities

  • Amphenol

    Interconnect and sensor systems company reporting Q2 2026 results and raising 2026 guidance tied to CommScope and AI datacom demand.

  • Richard Adam Norwitt

    CEO who attributed IT datacom sequential increase to AI-related products and discussed end-market demand uncertainty.

  • Craig A. Lampo

    CFO who discussed margin expansion drivers and provided guidance details.

Related articles

$APHMedAI 8/10

APH's Communications Growth Surges: Can Rivals Dent Its Momentum?

Amphenol (APH) reported strong Q2 2026 growth, with Communications Solutions revenue up 85% YoY, driven by AI-related IT datacom demand. IT datacom accounted for 43% of sales, growing 89% YoY. APH expects Q3 sales of $9.3-$9.4B and EPS of $1.40-$1.42. Rivals TE Connectivity (TEL) and Bel Fuse (BELFB) also show growth in AI connectivity.

$FNMedAI 8/10

Fabrinet Drops After Earnings Dragging Down Peers Like Marvell and Amphenol

Fabrinet (FN) fell 20% after reporting Q4 revenue of $1.316B and EPS of $4.10, but Q1 guidance was seen as decelerating. This dragged down peers like Marvell (MRVL, -8%), Amphenol (APH, -7%), Coherent (COHR, -12%), and Lumentum (LITE, -10%). Anthropic's lower-than-expected ARR and 30-year Treasury yields also contributed to the sell-off in AI hardware stocks.

$APHMed

Tech M&A Deals: Amphenol, Net at Work and Zedcrest Group

Today’s technology M&A activity includes acquisitions by Amphenol, Net at Work, and Zedcrest Group, expanding compliance testing technologies, managed IT and cybersecurity services, and cross-border payment infrastructure. Amphenol Acquires Wilder Technologies Amphenol announced the acquisition of Wilder Technologies, a U.S.-based manufacturer of compliance testing equipment for high-speed data communications and optical interconnects.

$MSFTMed

Stocks Tumble as Chipmakers Plunge, Oil Spikes

US MBA mortgage applications fell -6.4% in the week ended July 24, with the purchase mortgage sub-index down -3.6% and the refinancing mortgage sub-index down -9.9%. The average 30-year fixed rate mortgage rose +7 bp to an 11.5-month high of 6.76% from 6.69% the prior week. The outlook for strong Q2 earnings, which continue this week, is a bullish factor for stocks.